Synthesis, radiolabelling, and biological assessment of folic acid-conjugated G-3 99mTc-dendrimer as the breast cancer molecular imaging agent
In conclusion, the authors’ study documented the positive aspects of PEG-citrate dendrimer conjugated with folic acid as the SPECT contrast agent for breast cancer detection.
Source: IET Nanobiotechnology - Category: Nanotechnology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Folic Acid | Molecular Biology | Nanotechnology | SPECT | Study | Toxicology | Vitamin B9